Sponsor Dossier
Alphapharm
Sponsor Dossier for Alphapharm. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABACAVIR/LAMIVUDINE
- Brand: ABYRAZ
- Brand: ACAMPROSATE
- Brand: ACETEC
- Brand: ACICLOVIR
- Brand: ADENOSINE VIATRIS
- Brand: ADENOVIEW
- Brand: ADESAN
- Device (sponsor): Hypodermic needle, single-use, sterile
About
Alphapharm is an Australian Private Company with ABN 93 002 359 739, registered in NSW and currently active. The company has traded under the business names Mylan Australia and Viatris.
Portfolio
Alphapharm has 283 brands on the ARTG, of which 197 are indexable and 187 carry a Product Information document. 159 brands are PBS-listed, 12 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include ABACAVIR/LAMIVUDINE, ABYRAZ, ACAMPROSATE, ACETEC, ACICLOVIR, ADENOSINE VIATRIS, ADENOVIEW, ADESAN, ADRENALINE, AKAMIN, ALEPAM, ALLOPURINOL.
Therapeutic focus
— Cardiology: 66 brands — Infectious Disease: 49 brands — Psychiatry: 46 brands — Neurology: 25 brands — Endocrinology: 19 brands — Pain Management: 13 brands — Oncology: 12 brands — Gastroenterology: 11 brands — Musculoskeletal: 9 brands — Other: 6 brands — Immunology: 5 brands — Haematology: 5 brands — Respiratory: 4 brands — Reproductive Health: 4 brands — Dermatology: 3 brands — Rare Disease: 3 brands — Complementary Medicine: 1 brand — Renal: 1 brand — Ophthalmology: 1 brand
PBS footprint
159 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2024-11-01, across 12 brands with a PBAC outcome on record.